Dasotraline Binge Eating Disorder Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Binge Eating Disorder
Interventions
DRUG

Dasotraline

Dasotraline 4, 6, 8mg flexibly dosed once daily

DRUG

Placebo

Placebo once daily

Trial Locations (43)

10549

Bioscience Research, LLC, Mount Kisco

18104

Lehigh Center For Clinical Research, Allentown

20170

NeuroScience, Inc., Herndon

27612

Wake Research Associates, Raleigh

29621

Radiant Research, Inc., Anderson

29650

Radiant Research, Inc., Greer

30005

Institute of Advanced Medical Research, Alpharetta

30342

Neurotrials Research, INC., Atlanta

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

32801

Clinical Neuroscience Solutions, Inc., Orlando

33143

Miami Research Associates, South Miami

33161

Segal Institute for Clinical Research, North Miami

44130

North Star Medical Research, LLC, Middleburg Heights

44311

Radiant Research, Inc., Akron

45040

Lindner Center Of Hope, Mason

45215

Patient Priority Clinical Sites, Cincinnati

45417

Midwest Clinical Research Center, Dayton

46260

Goldpoint Clinical Research, Inc., Indianapolis

60048

Capstone Clinical Research, Libertyville

63304

St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles

67226

Cypress Medical Research Center, LLC, Wichita

73103

IPS Research Company, Oklahoma City

75093

Psychiatric Medical Associates, Plano

75231

Furturesearch Trials of Dallas, Dallas

77081

Texas Center for Drug Development, Inc., Houston

80209

Lytle and Weiss, PLLC, Denver

84123

Radiant Research, Inc., Murray

84405

Advanced Research Institute, Ogden

90210

Southern California Research, Beverly Hills

Southwestern Research, Inc., Beverly Hills

91316

Pharmacology Research Institute, Encino

92108

PCSD- Feighner Research, San Diego

92660

Pharmacology Research Institute, Newport Beach

92705

Research Across America, Santa Ana

92845

Collaborative NeuroScience Network Inc., Garden Grove

97214

Oregon Center for Clinical Investigatons, INC., Portland

97301

Oregon Center for Clinical Investigatons, INC., Salem

97504

Sunstone Medical Research, LLC, Medford

98104

Summit Research Network (Seattle) LLC, Seattle

02478

McLean Hospital, Belmont

02472

Adams Clinical Trials, LLC, Watertown

08540

Princeton Medical Institute, LCC, Princeton

05091

Neuropsychiatric Associates, Woodstock

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT02564588 - Dasotraline Binge Eating Disorder Study | Biotech Hunter | Biotech Hunter